I opened the headline and felt the room tilt. Paramount is pushing forward on a Warner Bros. acquisition and, at the same time, restarting G.I. Joe with two competing creative maps. You can almost hear the corporate mash-up inhaling and holding its breath.
I’ve been tracking studio moves long enough to tell you when something smells like strategic theater. You should care because this isn’t just another franchise reset; it’s a test of how power, reputation, and creative risk collide under one roof.
I read The Hollywood Reporter’s scoop naming Danny McBride and Max Landis.
The outlet says Paramount has two treatments in the works: one by Danny McBride and another by Max Landis. Sources told THR the studio might try to merge both takes into a single film; another source insists they’re separate projects. That contradiction is the kind of thing I file under “problems that will become headlines.”
Landis is a high-profile gamble. After accusations reported by The Daily Beast in 2017, his career stalled. Paramount Skydance’s recent pattern—bringing back figures with baggage, from John Lasseter at Skydance Animation to naming Brett Ratner to direct Rush Hour 4—shows a willingness to trade reputational heat for creative pedigree. The plan reads like a house of cards.
The studio has tried and failed to land a G.I. Joe hit before.
Paramount released live-action entries in 2009 and 2013, then a standalone Snake Eyes in 2021. None stuck the landing. You remember those films: big budgets, muddled tones, and lukewarm returns. Bringing in two writers now feels less like building a franchise and more like spinning a roulette wheel.
Danny McBride brings a comic voice that can sharpen satire or understudy sincerity; Landis brings a flair for high-concept hooks—but also baggage that studios must weigh against PR fallout. Paramount’s recent green-lighting moves around the Warner Bros. acquisition stack another incentive onto creative choices: they need marketable IP fast, and pressure changes priorities.
Who is writing the new G.I. Joe movie?
THR reports Danny McBride and Max Landis are each developing treatments. McBride is known for comedy and genre bending; Landis wrote Chronicle and created Dirk Gently. Two treatments means the studio can shop tonal directions or merge strengths—if they can agree on a single track.
I watched the PR engines kick into gear as this story spread.
Press cycles now act like signal flares: fast, loud, and often strategic. You get the headline, the follow-ups, and the thinly sourced denials. That pattern tells me the studio is testing reactions as much as it is assembling a film.
Skydance and Paramount are playing a game of risk allocation—put controversial names near big properties in hopes the box office swallows the controversy. That’s a calculated bet with public relations on one side and investor timelines on the other. The announcement feels less like a launch and more like a fever dream.
Will Paramount combine the two scripts into one movie?
Sources conflict. One version of events says the treatments will be combined; another says they’ll run separately. If I had to advise you: expect the studio to hedge. They’ll keep options open until focus groups, marketing calendars, and merger timelines force a single path.
You should also watch the cultural and legal backdrop. Studios no longer operate in a vacuum: social media backlash, investigative reporting, and a more vocal industry change how reputations move. Bringing back creators with public allegations is not a neutral decision; it’s a public bet on forgiveness, forgetfulness, or the strength of the IP.
There’s still business to watch: Paramount, Skydance, and whatever the Warner Bros. deal ultimately looks like will shape who gets creative control and budget. The studio’s next moves will tell you if this is an experiment in synergy or a scramble for headlines.
Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who.
I’ll keep following the sources, you should watch what the marketing sells, and together we’ll see whether this gamble makes sense or just makes noise—so what do you think Paramount is trying to prove?